Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Mar 2;84(2):478–484. doi: 10.1016/j.ijrobp.2011.12.037

Table 1.

Patient characteristics

Patients (n=80)
Age (years) 55 (25 - 89)

FIGO stage

 I 10 (12%)
 II 32 (40%)
 III 27 (34%)
 IV 11 (14%)

Histology

 Squamous cell ca. 69 (86%)
 Adenocarcinoma 11 (14%)

Brachytherapy

 Low-dose-rate 76 (95%)
 None (EBRT only) 4 (5%)

Chemotherapy 25 (31%)